ATH 11.1% 0.5¢ alterity therapeutics limited

Pran up 70% on Nasdaq pre market, page-15

  1. 17 Posts.
    lightbulb Created with Sketch. 1
    as memory serves it was only a couple of years ago that Prana was looking for a partner to help fund the further dog studies needed to get the planned phase 3 trial up and running for Huntingtons disease.  Professor Shoulson is still involved with the company and it would be interesting to know what he thinks about running a phase 3 trial on pbt2 considering that he was previously very keen on the idea
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $14.25K 2.930M

Buyers (Bids)

No. Vol. Price($)
66 81346070 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19609447 23
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.